How antipsychotics become anti-‘psychotic’ – from dopamine to salience to psychosis
- 1 August 2004
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 25 (8) , 402-406
- https://doi.org/10.1016/j.tips.2004.06.005
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Cognitive–behavioural therapy in first-episode and early schizophreniaThe British Journal of Psychiatry, 2004
- Transient changes in mesolimbic dopamine and their association with ‘reward’Journal of Neurochemistry, 2002
- Schizophrenia as a Disorder of NeurodevelopmentAnnual Review of Neuroscience, 2002
- A Rating Scale for Psychotic Symptoms (RSPS): Part I: theoretical principles and subscale 1: perception symptoms (illusions and hallucinations)Schizophrenia Research, 1999
- Pathways to schizophrenia: the impact of environmental factorsInternational Journal of Neuropsychopharmacology, 1999
- The Prodromal Phase of First-episode Psychosis: Past and Current ConceptualizationsSchizophrenia Bulletin, 1996
- The involvement of nucleus accumbens dopamine in appetitive and aversive motivationBehavioural Brain Research, 1994
- The Origins of DelusionThe British Journal of Psychiatry, 1992
- Reward, Motivation, Cognition: Psychobiology of Mesotelencephalic Dopamine SystemsPublished by American Geophysical Union (AGU) ,1986
- THE BRIEF PSYCHIATRIC RATING SCALEPsychological Reports, 1962